Pediatr. praxi. 2021;22(1):54-58 | DOI: 10.36290/ped.2021.009

Kawasaki disease associated with Covid-19 - two cases

MUDr. Luděk Ryba, MUDr. Pavel Rozsíval
Dětské a novorozenecké oddělení, Orlickoústecká nemocnice, Ústí nad Orlicí

We present two case reports that demonstrate the link between coronavirus SARS‑CoV-2 and Kawasaki disease.

Keywords: Kawasaki dissease, Kawasaki‑like, coronavirus SARS‑CoV-2, children.

Published: March 25, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryba L, Rozsíval P. Kawasaki disease associated with Covid-19 - two cases. Pediatr. praxi. 2021;22(1):54-58. doi: 10.36290/ped.2021.009.

Download citation

References

  1. Morris SB, Schwartz NG, Patel P, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS‑CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1450-1456. Go to original source... Go to PubMed...
  2. Belot A, Antona D, Renolleau S, et al. SARS‑CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill. 2020; 25(22). Go to original source... Go to PubMed...
  3. Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020; 383: 347-358. Go to original source... Go to PubMed...
  4. Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki‑like disease at the Italian epicentre of the SARS‑CoV-2 epidemic: an observational cohort study. Lancet 2020; 395(10239): 1771-1778. Go to original source... Go to PubMed...
  5. Burns JC, Kushner HI, Bastian JF, et al. Kawasaki disease: A brief history. Pediatrics 2000; 106(2): E27. Go to original source... Go to PubMed...
  6. Kawasaki T. Kawasaki disease. Proc Jpn Acad Ser B Phys Biol Sci. 2006; 82(2): 59-71. Go to original source... Go to PubMed...
  7. Harwood R, Allin B, Jones CE, et al. PIMS‑TS National Consensus Management Study Group. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS‑TS): results of a national Delphi process. Lancet Child Adolesc Health. 2020 Sep 18: S2352-4642(20)30304-7.
  8. Son MBF, Friedman K. Coronavirus disease 2019 (COVID-19): Multisystem inflammatory syndrome in children (MIS‑C) management and outcome. In: UpToDate, Post, FLD, KLS, SR, RGA (Ed), UpToDate, Waltham, MA, 2020
  9. de Graeff N, Groot N, Ozen S, et al. European consensus‑based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative. Rheumatology (Oxford). 2019; 58(4): 672-682. Go to original source... Go to PubMed...
  10. McCrindle BW, Rowley AH, Newburger JW, et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, Treatment, and Long‑Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 2017 Apr 25; 135(17): e927-e999. Go to original source... Go to PubMed...
  11. Doležalová P, Telekesová P, Němcová D, Hoza J. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol 2004; 31: 2295-2299. Go to PubMed...
  12. Jonat B, Gorelik M, Boneparth A, et al. Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children's Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow‑Up. Pediatr Crit Care Med. 2020 Sep 29. Epub ahead of print. Go to original source... Go to PubMed...
  13. Ahmed M, Advani S, Moreira A, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine 2020; 26: 100527. Epub 2020 Sep 4. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.